Clinical Trial: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07380230) titled 'Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients' on Jan. 19.

Brief Summary: 1. To evaluate the preventive and therapeutic effects of Qibei Jiedu Formula on acute radiation dermatitis in breast cancer patients, including the incidence of grade 2 or higher radiation dermatitis, wound healing time, and symptom relief.

2. To observe the safety profile of Qibei Jiedu Formula.

3. To investigate the potential role of Qibei Jiedu Formula in improving patients' quality of life.

4. To explore the potential mechanism of action of Qibei Jiedu Formula in preventing and...